Harper Sean E (CIK 0001541946)

Latest company ownership

AMGN - AMGEN INC

Role: EVP, Research & Development

Shares held

56,082

Last filed at

Jul 16, 2018

Confidence Score

50.0

2025Q4

Confidence Score History

2017Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jul 16, 2018	Jul 16, 2018	AMGEN INC	EVP, Research & Development	Sell	38.8	-1,525	-2.65%	✓	$298.5K
Jun 12, 2018	Jun 12, 2018	AMGEN INC	EVP, Research & Development	Sell	38.8	-1,525	-2.58%	✓	$281K
May 14, 2018	May 15, 2018	AMGEN INC	EVP, Research & Development	Sell	38.8	-1,525	-2.52%	✓	$265.5K
May 3, 2018	May 7, 2018	AMGEN INC	EVP, Research & Development	Sell	22.5	-736	-1.20%	✗	$124.7K
Apr 12, 2018	Apr 16, 2018	AMGEN INC	EVP, Research & Development	Sell	38.8	-1,525	-2.62%	✓	$263.3K
Mar 23, 2018	Mar 27, 2018	AMGEN INC	EVP, Research & Development	Sell	17.5	-7,549	-11.46%	✗	$1.3M
Mar 16, 2018	Mar 19, 2018	AMGEN INC	EVP, Research & Development	Sell	38.8	-1,525	-2.27%	✓	$289.4K
Feb 14, 2018	Feb 15, 2018	AMGEN INC	EVP, Research & Development	Sell	38.8	-1,525	-2.84%	✓	$265.6K
Jan 30, 2018	Feb 1, 2018	AMGEN INC	EVP, Research & Development	Sell	32.5	-1,059	-0.97%	✗	$205.6K
Jan 16, 2018	Jan 17, 2018	AMGEN INC	EVP, Research & Development	Sell	38.8	-1,525	-2.71%	✓	$283.1K
Dec 12, 2017	Dec 12, 2017	AMGEN INC	EVP, Research & Development	Sell	38.8	-1,525	-2.65%	✓	$269.7K
Nov 13, 2017	Nov 14, 2017	AMGEN INC	EVP, Research & Development	Sell	38.8	-1,525	-2.58%	✓	$261.7K
Oct 9, 2017	Oct 10, 2017	AMGEN INC	EVP, Research & Development	Sell	38.8	-1,525	-2.51%	✓	$283.6K